Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

BTSG vs TEM: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

BTSG Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 10–0 Matrix Metrics)

BTSG Overall Winner 6-Pillar Tally: BTSG 5 – 1 TEM Matrix Metrics: BTSG 10 – 0 TEM

As of Nov 17, 2026, BrightSpring Health Services, Inc. (BTSG) is the stronger overall head-to-head candidate over Tempus AI, Inc. (TEM) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). BTSG carries a Unified Composite Score of 43.7/100 (HOLD) at $69.55 (29.4x Forward P/E, 3.5% operating margin), whereas TEM carries 43.5/100 (HOLD) at $63.08 (N/M Forward P/E, -18.5% operating margin).

  • Technical & Structure Timing Caution: BTSG trades in a Markup technical trend (CONSOLIDATION options phase, RSI 59.4); meanwhile TEM is in a Breakdown options structure phase (RSI 40.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About BTSG vs TEM
BTSG NASDAQ Head-to-Head Winner
BrightSpring Health Services, Inc. Common Stock
Services-Home Health Care Services
$69.55
-2.55% 1D
Market Cap $14.2B
TTM Revenue $10.4B
Forward P/E 29.4x
Beta / 30D Vol 0.93β · 54% Vol
Unified Composite Score
43.7 / 100 HOLD
Tech 32.0 Fund 40.0 Flow 57.0 Mom 40.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (4.2% over 20 days), RSI 59
RSI-14: 59.4 · SMA20: $66.20 · SMA50: $62.29
TEM NASDAQ
Tempus AI, Inc. Class A Common Stock
Services-Computer Programming, Data Processing, Etc.
$63.08
-2.59% 1D
Market Cap $13.1B
TTM Revenue $1.51B
Forward P/E N/M
Beta / 30D Vol 2.51β · 93% Vol
Unified Composite Score
43.5 / 100 HOLD
Tech 31.0 Fund 51.0 Flow 67.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 40
RSI-14: 40.3 · SMA20: $73.18 · SMA50: $72.83

6-Pillar Scorecard Institutional Category Breakdown (BTSG 5 – 1 TEM)

Columns: Metric · BTSG · TEM
1. Valuation Multiples BTSG
Forward P/E 29.4x N/M
Trailing P/E 50.5x N/M
PEG Ratio N/M N/M
EV / Revenue 1.5x 9.2x
2. Growth & Scale BTSG
Revenue Growth (YoY) +26.4% +23.1%
Earnings Growth (YoY) +82.0% +0.0%
TTM Revenue (USD) $10.4B $1.51B
Market Cap $14.2B $13.1B
3. Profitability & Quality BTSG
Gross Margin 12.5% 64.5%
Operating Margin 3.5% -18.5%
Net Profit Margin 2.7% -12.5%
Return on Equity (ROE) 15.5% -37.5%
4. Balance Sheet & Cash Flow BTSG
Cash Generation (TTM) $337M -$151M
Cash Flow Margin 3.2% -10.0%
Net Cash / Leverage $1.14B Net Debt (1.09x D/E) $841M Net Debt (2.86x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning BTSG
Options Structure Phase CONSOLIDATION BREAKDOWN
Current IV / %ile 48.7% (34th %ile) 99.3% (44th %ile)
Put/Call OI Skew 1.37x (Put-Skewed) 0.49x (Call-Skewed)
OBV Trend / Tech Phase ACCUMULATION · Markup DISTRIBUTION · Neutral
6. R&D & Supply-Chain Moat TEM
OpEx & R&D Intensity 9.0% of Rev ($939M) 83.0% of Rev ($1.25B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Ecosystem & Network-Effect Moat
Supply-Chain Role Health Information Services Operator Health Information Services Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: BTSG (10) vs TEM (0)
Institutional Metric BTSG TEM Criterion Row Edge
Market Capitalization
Scale
$14.2B $13.1B Larger Scale BTSG
Trailing P/E Ratio
Valuation
50.5x N/M Lower Multiple BTSG
Forward P/E Ratio
Valuation
29.4x N/M Lower Multiple BTSG
Revenue Growth (YoY)
Growth
+26.4% +23.1% Higher Growth BTSG
Operating Margin (TTM)
Profitability
3.5% -18.5% Higher Margin BTSG
Net Profit Margin
Profitability
2.7% -12.5% Higher Margin BTSG
Return on Equity (ROE)
Capital Efficiency
15.5% -37.5% Higher ROE BTSG
52-Week Range Position
Momentum
90% ($31–$74) 46% ($41–$89) Stronger Trend BTSG
Beta / 30D Volatility
Risk Regime
0.93β · 54% Vol 2.51β · 93% Vol Lower Realized Risk BTSG
Unified Institutional Score
Composite Signal
43.7 / 100 (HOLD) 43.5 / 100 (HOLD) Higher Composite BTSG
Trailing 12M Revenue (USD)
Operating Scale
$10.4B $1.51B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
12.5% 64.5% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 1.5x EV/Rev N/M PEG · 9.2x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$337M ($1.14B Net Debt (1.09x D/E)) -$151M ($841M Net Debt (2.86x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon BTSG +15.44 pp
BTSG: +13.48% · TEM: -1.96%
3M Horizon BTSG +14.24 pp
BTSG: +17.23% · TEM: +2.99%
6M Horizon TEM +15.93 pp
BTSG: +22.62% · TEM: +38.55%
1Y Horizon BTSG +125.23 pp
BTSG: +117.34% · TEM: -7.89%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period BTSG Revenue TEM Revenue BTSG Op. Margin TEM Op. Margin Margin Leader
FY2022 $7.72B $320M 2.4% -82.8% BTSG
FY2023 $7.69B $530M 0.8% -36.9% BTSG
FY2024 $10.1B $690M 1.1% -99.7% BTSG
FY2025 $12.9B $1.27B 2.3% -19.9% BTSG

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
BTSG CONSOLIDATION
101d in phase · OBV ACCUMULATION
Current IV 48.7%
IV Percentile 34th %ile
Put/Call OI Skew 1.37x (Put-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow ACCUMULATION
Exact BTSG Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
TEM BREAKDOWN
36d in phase · OBV DISTRIBUTION
Current IV 99.3%
IV Percentile 44th %ile
Put/Call OI Skew 0.49x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact TEM Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $69.67 · IV 45.1%

BTSG vs. TEM: Simulated 5-Day Option Payoffs & Capital Efficiency

Compare 100 shares of BTSG ($6,967) vs. TEM ($6,476) against risk-defined 5-day vertical and put-wall option structures.

BTSG Spot $69.67 · IV 45.1%
BTSG Options Simulator →
5-DAY BULLISH SWING Liq B

Dec 18 $70 / $75 Bull Call Spread

Buy 1x $70C · Sell 1x $75C · 31d

Net Entry $253 Debit
T+5d @ +5% Move +$58 (+23%)
Max Risk / Buffer $253 Capped
5d Edge & Liquidity 0.7x R:R · Liq B
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq C

Jan 15 '27 $65 / $60 Bull Put Spread

Sell 1x $65P · Buy 1x $60P · 59d

Net Entry $70 Credit
Max Credit / Yield +$70 (+16.3% RoM)
Max Risk / Buffer -7.7% Cushion ($430 Mgn)
5d Edge & Liquidity 72% PoP · Liq C
Simulate 5-Day Payoff →
TEM Spot $64.76 · IV 84.1%
TEM Options Simulator →
5-DAY BULLISH SWING Liq A

Dec 18 $65 / $75 Bull Call Spread

Buy 1x $65C · Sell 1x $75C · 32d

Net Entry $365 Debit
T+5d @ +5% Move +$69 (+19%)
Max Risk / Buffer $365 Capped
5d Edge & Liquidity 0.7x R:R · Liq A
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq A

Dec 18 $60 / $55 Bull Put Spread

Sell 1x $60P · Buy 1x $55P · 32d

Net Entry $160 Credit
Max Credit / Yield +$160 (+47.1% RoM)
Max Risk / Buffer -9.8% Cushion ($340 Mgn)
5d Edge & Liquidity 68% PoP · Liq A
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
BTSG Moat Profile Cyclical / Execution-Driven Positioning
Health Information Services Operator
Competes within the Health Information Services value chain with $14.2B market capitalization and 3.5% operating margin.
OpEx & R&D Reinvestment 9.0% of Rev ($939M)
90D Engineering Disclosures 0 Published
TEM Moat Profile Ecosystem & Network-Effect Moat
Health Information Services Operator
Competes within the Health Information Services value chain with $13.1B market capitalization and -18.5% operating margin.
OpEx & R&D Reinvestment 83.0% of Rev ($1.25B)
90D Engineering Disclosures 0 Published · AI Drug Discovery

Investor FAQ BTSG vs TEM Key Questions & Quantitative Answers

As of Nov 17, 2026, BrightSpring Health Services, Inc. (BTSG) is the stronger overall head-to-head candidate over Tempus AI, Inc. (TEM) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). BTSG carries a Unified Composite Score of 43.7/100 (HOLD) at $69.55 (29.4x Forward P/E, 3.5% operating margin), whereas TEM carries 43.5/100 (HOLD) at $63.08 (N/M Forward P/E, -18.5% operating margin). Technical & Structure Timing Caution: BTSG trades in a Markup technical trend (CONSOLIDATION options phase, RSI 59.4); meanwhile TEM is in a Breakdown options structure phase (RSI 40.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

BTSG leads the Growth & Scale pillar: BTSG posts +26.4% YoY revenue growth and +82.0% YoY earnings growth on $10.4B TTM revenue (12.5% gross margin, 3.5% operating margin), compared with TEM at +23.1% YoY revenue growth and +0.0% YoY earnings growth on $1.51B TTM revenue (64.5% gross margin, -18.5% operating margin). Across the 4-period historical trajectory (FY2022 to FY2025), BTSG cumulative revenue shifted +67.2% while TEM shifted +296.9%. In operating R&D and SG&A reinvestment, BTSG deploys 9.0% of Rev ($939M) (0 90-day corporate R&D disclosures) versus 83.0% of Rev ($1.25B) (0 disclosures) for TEM.

BTSG screens cheaper on headline valuation multiples. BTSG trades at 29.4x Forward P/E, 50.5x Trailing P/E, N/M PEG, and 1.5x EV/Revenue (3.2% FCF margin), whereas TEM trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 9.2x EV/Revenue (-10.0% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BTSG (15.5% ROE) versus TEM (-37.5% ROE) capital efficiency.

In options market volatility and institutional positioning, BTSG carries 48.7% implied volatility (34th %ile, Balanced (25th–60th %ile)), a 1.37x (Put-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.93β · 54% Vol realized risk). By comparison, TEM carries 99.3% implied volatility (44th %ile, Balanced (25th–60th %ile)), a 0.49x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (2.51β · 93% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.